<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE327nnn/GSE327307/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE327307</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>DOT1L shapes ncPRC1-target gene repression to maintain cell identity of DLBCL [RNA-Seq]</name><description>Germinal center (GC) B cell-like diffuse large B cell lymphoma (GCB-DLBCL) depends on the cooperative activity of the histone methyltransferases DOT1L and EZH2 to maintain its pro-proliferative GCB cell identity while repressing plasma cell (PC) differentiation. To explore the mechanisms underlying the co-dependency between DOT1L and EZH2 in GCB-DLBCL, we performed an EZH2 inhibition (EZH2i)-anchored genome-wide CRISPR interference screen and identified multiple candidate genes encoding components of non-canonical (nc) PRC1 complexes, including USP7, KDM2B, RING1, and PCGF1. We identified USP7 as potential direct target of DOT1L, whose downregulation was associated with increased EZH2i sensitivity in multiple GCB-DLBCL cell lines. Furthermore, we observed that DOT1L influences the composition of chromatin-bound ncPRC1 complexes and regulates, in part, the deposition of H2AK119 monoubiquitination (H2AK119ub1) at gene promoters co-occupied by H3K27me3, here defined as PRC1/2 target genes. These PRC1/2 targets were specifically enriched in PC signature genes, whose derepression was associated with DOT1L inhibition (DOT1Li)-mediated loss of H2AK119ub1. This study reveals novel insights into the role of DOT1L and its functional co-dependence with EZH2 in maintaining GCB identity in DLBCL, supporting a model in which concurrent reduction of H2AK119ub1 and H3K27me3 promotes differentiation toward an anti-proliferative, plasma cell–like state.</description><dates><publication>2026/06/19</publication></dates><accession>GSE327307</accession><cross_references><GSM>GSM9653220</GSM><GSM>GSM9653221</GSM><GSM>GSM9653210</GSM><GSM>GSM9653211</GSM><GSM>GSM9653222</GSM><GSM>GSM9653223</GSM><GSM>GSM9653212</GSM><GSM>GSM9653217</GSM><GSM>GSM9653206</GSM><GSM>GSM9653218</GSM><GSM>GSM9653207</GSM><GSM>GSM9653208</GSM><GSM>GSM9653219</GSM><GSM>GSM9653209</GSM><GSM>GSM9653224</GSM><GSM>GSM9653213</GSM><GSM>GSM9653214</GSM><GSM>GSM9653203</GSM><GSM>GSM9653225</GSM><GSM>GSM9653226</GSM><GSM>GSM9653215</GSM><GSM>GSM9653204</GSM><GSM>GSM9653205</GSM><GSM>GSM9653216</GSM><GPL>24676</GPL><GSE>327307</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>